Katsuki, Fujika
Watanabe, Norio
Kondo, Masaki
Sawada, Hanayo
Yamada, Atsurou
Article History
Received: 7 February 2024
Accepted: 25 April 2024
First Online: 17 May 2024
Declarations
:
: This study was approved by the Ethics Review Committee of Nagoya City University Graduate School of Nursing, Japan (Ref: No 22033-4). All participants will be provided written informed consent to participate in the study.
: Not applicable.
: FK received speaker’s fees from Otsuka Pharmaceutical Co., Ltd. MK received speaker's fees from Takeda Pharmaceutical Co., Ltd. and Sumitomo Pharma Co., Ltd. HS declares no conflicts of interest. AY is an employee of a course endowed by Nagoya City and received medical fees from Gifu Hospital, speaker's fees from Aichi Education and Sports Foundation, Viatris Pharmaceutical Co., Ltd., Takeda Pharmaceutical Co., Ltd, Otsuka Pharmaceutical Co., Ltd., Nobel Pharma Co., Ltd., Shionogi Pharmaceutical Co., Ltd., Mental Care Association Japan, instructor fees from Asamidori no Kai, a social welfare corporation, consulting fees from Yohaku Bunka Co., Ltd. and other fees from Nagoya City. NW has received royalties from Sogensha, Medical View, and Advantage Risk Management for writing.